Prostate-specific antigen (PSA) kinetics in patients (pts) with advanced prostate cancer treated with apalutamide: Results from the TITAN and SPARTAN studies.

Kim N.  Chi

Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi

Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; ESSA; Janssen; Roche; Sanofi

Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Lilly/ImClone (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); Tokai Pharmaceuticals (Inst)

Fred  Saad

Honoraria - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bayer; Janssen Oncology; Sanofi

Consulting or Advisory Role - Astellas Pharma; AstraZeneca/MedImmune; Bayer; Janssen Oncology; Sanofi

Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Pfizer (Inst); Sanofi (Inst)

Simon  Chowdhury

Honoraria - Clovis Oncology; Novartis

Consulting or Advisory Role - Astellas Pharma; Bayer; Clovis Oncology; Janssen-Cilag; Pfizer

Speakers' Bureau - Pfizer

Research Funding - Sanofi/Aventis (Inst)

Julie N  Graff

Honoraria - Astellas Medivation; Bayer; Bayer; Bayer; Janssen Oncology; Janssen Oncology; Janssen Oncology; Janssen Oncology; Sanofi; Valeant/Dendreon

Consulting or Advisory Role - Exelixis

Speakers' Bureau - i3 CME

Research Funding - Janssen Oncology (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Sanofi (Inst)

Patents, Royalties, Other Intellectual Property - Oncoresponse: Exceptional responders

Travel, Accommodations, Expenses - Bayer; Clovis Oncology; Merck Sharp & Dohme; Merck Sharp & Dohme; Sanofi

Neeraj  Agarwal

Consulting or Advisory Role - Astellas Pharma; AstraZeneca; AstraZeneca; Bayer; Bristol-Myers Squibb; Exelixis; Foundation Medicine; Foundation One Inc; Janssen Oncology; Lilly; Lilly; Lilly; Medivation/Astellas; Merck; Nektar; Novartis; Pfizer; Pfizer; Pharmacyclics

Research Funding - Active Biotech (Inst); Amgen (Inst); AstraZeneca (Inst); Bavarian Nordic (Inst); Bayer (Inst); BN ImmunoTherapeutics (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celldex (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Janssen (Inst); Merck (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); Prometheus (Inst); Rexahn Pharmaceuticals (Inst); Sanofi (Inst); Takeda (Inst); TRACON Pharma (Inst)

Stephane  Oudard

Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; IPSEN; Janssen; Merck; MSD; Novartis; Pfizer; Roche/Genentech; Sanofi

Consulting or Advisory Role - Astellas Pharma; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; IPSEN; Janssen; Merck; MSD Oncology; MSD Oncology; Novartis; Pfizer; Roche; Roche; Sanofi

Research Funding - Ipsen; Sanofi

Travel, Accommodations, Expenses - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Merck; MSD Oncology; Novartis; Pfizer; Roche

Gang  Li

Employment - Janssen Research & Development

Stock and Other Ownership Interests  - Johnson & Johnson

Angela  Lopez-Gitlitz

No Relationships to Disclose

Julie S.  Larsen

Employment - Janssen Research & Development

Stock and Other Ownership Interests  - Johnson & Johnson

Sharon Anne  McCarthy

Employment - Janssen Research & Development

Stock and Other Ownership Interests  - Johnson & Johnson

Suneel  Mundle

No Relationships to Disclose

Matthew Raymond  Smith

Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Janssen Oncology; Lilly; Novartis; Pfizer

Research Funding - Bayer (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Lilly (Inst)

Travel, Accommodations, Expenses - Amgen; Bayer; Janssen; Lilly

Eric Jay  Small

Stock and Other Ownership Interests  - Fortis; Harpoon Therapeutics

Honoraria - Janssen

Consulting or Advisory Role - Beigene; Fortis; Janssen Oncology; Teon Therapeutics; Tolero Pharmaceuticals

Research Funding - Janssen (Inst); Merck (Inst)

Travel, Accommodations, Expenses - Janssen